Top Markets
#1 DogBull DogBull +105.44%
#2 Siacoin Siacoin +49.01%
#3 ADO Protocol ADO Protocol +47.01%
#4 UnifAI Network UnifAI Network +43.78%
#5 MarsCoin MarsCoin +39.76%
#6 Magma Finance Magma Finance +32.17%
#7 Useless Coin Useless Coin +27.08%
#8 Ontology Gas Ontology Gas +18.64%
#9 Nockchain Nockchain +16.11%
#10 Apertum Apertum +14.70%
Coin of the day
DogBull DogBull
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Cuorips Inc. Cuorips Inc.

Cuorips Inc.

4894
Clasificación en acciones #16184
Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived... Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
Precio por acción
$37.25
Capitalización bursátil
$307.63M
Cambio (1 día)
-1.55%
Cambio (1 año)
-26.02%
País
JP
Comercio Cuorips Inc. (4894)

Categoría

Healthcare
Ganancias de Cuorips Inc. (4894)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Cuorips Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Cuorips Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH